Tenderwize
Back to tender search

Open house Arzneimittelrabattverträge Fondaparinux, ATC B01AX05

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline May 03, 2028 · 625 days left·Open·Supplies·Framework
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Fondaparinux, ATC B01AX05

60/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

60 / 100

Complexity

20 / 100

Risk factors

No minimum purchasing volume or guaranteed revenue; actual business depends on market conditions.

Contracts automatically terminate if another rebate contract for the same substance enters into force via an open proce...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jun 2028
  • Supply of Fondaparinux (ATC B01AX05) under non-exclusive rebate agreements with AOK Bayern.
  • Agreements are governed by §130a Abs. 8 SGB V and are not subject to procurement law.
Show full summary

Open house model for non-exclusive pharmaceutical rebate agreements for Fondaparinux (ATC B01AX05) by AOK Bayern. Any eligible pharmaceutical company can join without competitive selection. Contract period from 01.07.2026 to 30.06.2028. Submission of signed contract and declaration of reliability required. No estimated value provided. Note: Structured data indicates EU funding, but XML notice states no EU funds (inconsistency).

Risks

No minimum purchasing volume or guaranteed revenue; actual business depends on market conditions.

Contracts automatically terminate if another rebate contract for the same substance enters into force via an open proce...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Eligibility

  • Only pharmaceutical companies are eligible.

Administrative

  • Must submit a signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit).
  • Must submit the signed contract and annex 'Festlegung der vertragsgegenständlichen Arzneimittel'.

Requirements may be incomplete.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open house Arzneimittelrabattverträge Fondaparinux, ATC B01AX05

Non-exclusive rebate agreements for the active substance Fondaparinux (ATC B01AX05) with AOK Bayern. All eligible pharmaceutical companies may join. Contract terms are identical and non-negotiable.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Jun 2026 - Jun 2028

Category

Pharmaceutical products

Procurement Details

Publication date
17 May 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
335740-2026

Documents (2)

Similar tenders